Biotransformation of quinoxaline by Streptomyces badius
Related Experiment Video
Updated: Nov 4, 2026

Green Synthesis of Quinoline-Based Ionic Liquid
Published on: September 27, 2024
J B Sutherland1, F E Evans, J P Freeman
1National Center for Toxicological Research, Food and Drug Administration, Jefferson, AR 72079, USA. jsutherland@fdant.nctr.fda.gov
Abstract:
Quinoxaline, a mutagenic azaarene produced in foods during cooking, was added to cultures of Streptomyces badius ATCC 39117. After 24 h, the cultures were extracted with ethyl acetate. Two major metabolites were purified by liquid chromatography and identified by mass spectrometry and nuclear magnetic resonance spectroscopy as 3,4-dihydro-2(1H)-quinoxalinone and 2(1H)-quinoxalinone.
Related Concept Videos
Drug Biotransformation: Overview
Drug Biotransformation: Overview
Production of Antibiotics
Gene Regulation in Microbial Communities: Quorum Sensing
Drug Metabolism: Phase II Reactions
Microbial Bioremediation of Uranium

